Abstract
DSM and Evonik Industries are setting up a joint venture to make omega-3 fatty acids from natural marine algae for use in fish feed and pet food. The venture, called Veramaris, will spend $200 million to build an omega-3 fatty acid facility at an existing Evonik site in the U.S. It will go onstream in 2019. The firms have already made pilot-scale quantities of the oil at DSM’s facility in Kingstree, S.C. The new plant will turn out a “highly concentrated algal oil,” the partners say, using algae production expertise from DSM and industrial-scale fermentation know-how from Evonik. Omega-3 fatty acids are a family of polyunsaturated fats that include eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). Initial output from the planned facility will meet about 15% of the farmed salmon industry’s demand for EPA and DHA, the two firms say. Fish use omega-3 for metabolic functions and as a cellular
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
